Chemists move closer toward developing safer, fully-synthetic form of heparin

August 17, 2008

Chemists are reporting a major advance toward developing a safer, fully-synthetic version of heparin, the widely used blood thinner now produced from pig intestines. The U. S. Food and Drug Administration last spring linked contaminated batches of the animal-based product, imported from China, to more than 80 deaths and hundreds of allergic reactions among patients exposed to the drug for kidney dialysis and other conditions.

Described here today at the ACS's 236th National Meeting, the purer, non-animal version could improve the drug's safety and bolster regulatory control of its manufacture, the researchers say. Scientists expect demand for heparin, which prevents blood clots, to increase in the future due to rising rates of diabetes, heart disease, and other health complications linked to sedentary lifestyles. Global heparin sales total about $4 billion annually.

"With the problems associated with contaminated heparin produced from pig tissues in China, a non-animal source of this essential drug is gaining importance," says study co-author Robert J. Linhardt, Ph.D., a chemist with Rensselaer Polytechnic Institute in Troy, New York. "A safer version of the drug could result in less adverse effects and fewer deaths."

Heparin can be given by injection to prevent life-threatening blood clots during heart surgery and kidney dialysis. It also is used to clean intravenous lines used in those procedures. Because heparin is difficult to make in the lab from scratch, the drug's only source has been from pig intestines.

Linhardt points out that processing of pig intestines to extract the raw materials is often done in small, family-run workshops in China, which supplies about 70 percent of the world's heparin. Those mom-and-pop shops often fall outside the normal supervision and regulatory control standard in the pharmaceutical industry. The lack of oversight increases the risks of heparin contamination or adulteration with harmful chemicals, viruses, or other agents, he says.

"If heparin is prepared the right way, it should be consistent and safe, even from an animal source," says Linhardt, who was part of the team that identified the suspected chemical contaminant in the Chinese heparin. The contaminant, called oversulfated chondroitin sulfate, can cause life-threatening allergic reactions. Heparin supplies containing the contaminant have now been recalled.

Researchers have been trying for years to develop heparin production methods that don't require pig intestines. The first so-called total synthesis of heparin, developed in 2003 at the Massachusetts Institute of Technology (MIT), was not practical. It produced only minute batches of heparin — less than 0.000000035 ounces at a time — and could not be scaled up for commercial use, Linhardt says.

Working with Jian Liu, Ph.D., a medicinal chemist with the University of North Carolina-Chapel Hill, and Jonathan Dordick, Ph.D., a Rensselaer chemical engineer, Linhardt's team now has developed an alternative synthesis method that boosts heparin production a million times higher than the MIT technique. The scientists employed a patented biotechnology approach that uses powerful enzymes to string together the individual carbohydrate units that form the pure heparin polymer. "Our biotech version of heparin will be prepared in a controlled environment ensuring that it is pure and free of contaminants," Linhardt says.

So far, only small amounts of the new heparin have been produced in the laboratory using this technique, called "chemoenzymatic synthesis." But Linhardt reports that the new approach can be used to produce the drug on a larger scale suitable for industrial manufacture. Cost, dosing, and administration of the new drug should be the same as conventional, animal-based heparin, he notes.

Linhardt plans to begin testing the synthetic heparin on animals this summer. If these and other tests are successful, the new heparin could reach the consumer market in two to five years, he estimates. The National Institutes of Health provided primary funding for the project.

Source: American Chemical Society

4.3 /5 (3 votes)  

Rank 4.3 /5 (3 votes)
Relevant PhysicsForums posts

More news stories

Hydrogen from acidic water: Researchers develop potential low cost alternative to platinum for splitting water

A technique for creating a new molecule that structurally and chemically replicates the active part of the widely used industrial catalyst molybdenite has been developed by researchers with the Lawrence Berkeley ...

Chemistry / Materials Science

created Feb 09, 2012 | popularity 4.8 / 5 (15) | comments 21 | with audio podcast

Fool's gold may prove an unlikely alternative to overexploited catalytic materials

Catalytic materials, which lower the energy barriers for chemical reactions, are used in everything from the commercial production of chemicals to catalytic converters in car engines. However, with current catalytic materials ...

Chemistry / Materials Science

created Feb 10, 2012 | popularity 4.4 / 5 (8) | comments 8 | with audio podcast

Research provides octagonal window of opportunity for carbon capture

(PhysOrg.com) -- Filtering carbon dioxide, a greenhouse gas, from factory smokestacks is a necessary, but expensive part of many manufacturing processes. However, a collaborative research team from the National ...

Chemistry / Materials Science

created Feb 08, 2012 | popularity 5 / 5 (1) | comments 5 | with audio podcast

Flexible paper robots

(PhysOrg.com) -- These inexpensive robots can stretch, bend and twist under control, and lift objects up to 120 times their own weight. Being soft, they can apply gentle and even pressure, and adapt to varied ...

Chemistry / Materials Science

created Feb 09, 2012 | popularity 5 / 5 (5) | comments 4 | with audio podcast

New form of hafnium oxide developed

(PhysOrg.com) -- A novel material developed by researchers at the University of Cambridge is opening up new possibilities for next generation electronic and optoelectronic devices, and paving the way for further ...

Chemistry / Materials Science

created Feb 07, 2012 | popularity 4.6 / 5 (5) | comments 4 | with audio podcast


Walney offshore wind farm is world's biggest (for now)

(PhysOrg.com) -- The Walney wind farm on the Irish Sea--characterized by high tides, waves and windy weather--officially opened this week. The farm is treated in the press as a very big deal as the Walney ...

GPS court ruling leaves US phone tracking unclear

A US Supreme Court decision requiring a warrant to place a GPS device on the car of a criminal suspect leaves unresolved the bigger issue of police tracking using mobile phones, legal experts say.

Europeans protest controversial Internet pact

Tens of thousands of people marched in protests in more than a dozen European cities Saturday against a controversial anti-online piracy pact that critics say could curtail Internet freedom.

Europe stakes billion-dollar bet on new rocket

A pencil-slim rocket is scheduled to lift into space from South America on Monday, carrying a billion-dollar bet that Europe can grab a juicy slice of the market to place satellites in low orbit.

Study finds that anti-diabetic medication can prevent the long-term effects of maternal obesity

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that show that short therapy with the anti-diabetic medication ...

Netflix settlement trims 14 pct off 4Q earnings

(AP) -- Netflix pressed the rewind button on its fourth-quarter earnings after settling allegations that the video subscription service violated a consumer-privacy law.